Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid for reducing blood loss during and after caesarean section
PACTR202406748563034Completed
- Sponsor
- Okere Chinonso
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Okere Chinonso. Primary endpoint: Blood loss reduction during and after caesarean section. Started Jun 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202406748563034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406748563034.